The mechanism, how SGOL1 knockout contributes to an increased sorafenib sensitivity remained unclear, as SGOL1 knockdown did not result in a greater amount of apoptotic HCC cells after sorafenib treatment in comparison to control cells (Sun et al., 2018). The gene discussed is SGO1; the disease is hepatocellular carcinoma.